GARDP announces partnership with Calibr, HZI/HIPS and the University of Queensland in search for new antibiotics 11/04/2019 Editorial team [GARDP Press Release] [Geneva/San Francisco/Brisbane/Saarbrücken – 11 April 2019] Multi-actor partnership tests natural products and compound libraries for antibacterial activity Discovery efforts will focus on World Health Organization’s (WHO) priority pathogens The Global Antibiotic Research and Development Partnership (GARDP) is partnering with Calibr, the Helmholtz Centre for Infection Research (HZI), in particular its location Helmholtz-Institute […] Continue reading -> GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
GARDP Set Up As Independent Legal Entity 02/04/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 2 April 2019 Continued close collaboration with founding partners will strengthen GARDP’s efforts to address AMR The Global Antibiotic Research and Development Partnership (GARDP) is now an independent legal entity following a successful three-year incubation, hosted by the Drugs for Neglected Diseases initiative (DNDi). During this time, GARDP has already begun […] Continue reading -> WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
WHO Stakeholders Meet To Establish A “Different Approach” For Post-2020 Vaccine Strategy 21/03/2019 David Branigan The World Health Organization and global partners wrapped up a meeting today to develop a vision and strategy prototype for the post-2020 decade of action on vaccines and immunizations. This new plan of action for 2021-2030 will take a different approach that is more “bottom up” and collaborative in engaging countries and other stakeholders to […] Continue reading -> New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
New Study Finds Better Sewage Management Critical To Combatting AMR 18/03/2019 Elaine Ruth Fletcher Bacteria and other pathogens that are resistant to common anti-microbial medications appear to be most abundant in Africa, as well as parts of South-East Asia and other developing regions with a poor record of sewage and sanitation management, according to a new study published in Nature Communications. Image Credits: Wikimedia Commons. Continue reading -> DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
DNDi-led Study Finds Safer, Shorter Treatment For Debilitating Chagas Disease 15/03/2019 Divya Schlesinger Severe side effects make the current course of prolonged drug treatment difficult for many patients with Chagas disease, but a Phase II clinical trial in Bolivia may have found an alternative treatment that is both quicker and significantly safer. Image Credits: Ana Ferreira/DNDi. Continue reading -> Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Landmark International Guidelines Launched On Human Rights, Drug Policy 15/03/2019 Editorial team As posted by UNAIDS and UNDP in a press release: VIENNA/GENEVA, 15 March 2019—A coalition of United Nations Member States, United Nations entities and leading human rights experts meeting at the Commission on Narcotic Drugs in Vienna, Austria, today launched a landmark set of international legal standards to transform and reshape global responses to the world drug […] Continue reading -> Posts navigation Older postsNewer posts